PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $935,000 | -7.9% | 20,000 | 0.0% | 0.04% | -22.8% |
| Q2 2020 | $1,015,000 | +10.4% | 20,000 | -2.9% | 0.06% | -20.8% |
| Q1 2020 | $919,000 | -63.6% | 20,596 | -60.8% | 0.07% | -48.6% |
| Q4 2019 | $2,526,000 | +149.1% | 52,596 | +75.3% | 0.14% | +115.4% |
| Q3 2019 | $1,014,000 | +125.3% | 30,000 | +200.0% | 0.06% | +150.0% |
| Q2 2019 | $450,000 | -14.6% | 10,000 | -28.6% | 0.03% | -18.8% |
| Q1 2019 | $527,000 | -28.7% | 14,000 | -34.9% | 0.03% | -34.7% |
| Q4 2018 | $739,000 | – | 21,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |